A Review of the Comparative Anatomy, Histology, Physiology and Pathology of the Nasal Cavity of Rats, Mice, Dogs and Non-human Primates. Relevance to Inhalation Toxicology and Human Health Risk Assessment

Autor: Chamanza, R., Wright, J.A.

Publikováno v: In Journal of Comparative Pathology November 2015 153(4):287-314

A ventricular septal defect in a juvenile ostrich (Struthio camelus): A case report

Autor: Sikala, E T, Chamanza, R., Zimhunga, T, Erlwanger, K

Publikováno v: Zimbabwe Veterinary Journal; Vol 32, No 2 (2001); 76-80

(Zimbabwe Veterinary Journal, 2001, 32 (3&4): 76-80)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::59f372f7259b0089e6a74ca559e19e80
https://www.ajol.info/index.php/zvj/article/view/5366

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P07-12 Impaired renal function is a confounding factor in the use of plasma citrulline as a marker of intestinal toxicity in rodents.

Autor: Jardi, F.¹ (AUTHOR), van Heerden, M.¹ (AUTHOR), Chamanza, R.¹ (AUTHOR), Frisk, A.-L.¹ (AUTHOR), Verslegers, M.¹ (AUTHOR), De Jonghe, S.¹ (AUTHOR), Breidenbach, L.² (AUTHOR), Trairatphisan, P.² (AUTHOR), Kunnen, S.³ (AUTHOR), Wijaya, L.S.³ (AUTHOR), Feyen, B.¹ (AUTHOR), Blasco, N. Maicas¹ (AUTHOR), Yanochko-Hoffman, G.¹ (AUTHOR)

Publikováno v: Toxicology Letters. 2024 Supplement 2, Vol. 399, pS169-S169. 1p.

Complex In Vitro Model Characterization for Context of Use in Toxicologic Pathology: Use Cases by Collaborative Teams of Biologists, Bioengineers, and Pathologists.

Autor: Stokar-Regenscheit N; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Bell L; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Berridge B; B2 Pathology Solutions LLC, Cary, North Carolina, USA., Rudmann D; Charles River Laboratories, Ashland, Ohio, USA., Tagle D; National Center for Advancing Translational Sciences/National Institutes of Health, Bethesda, Maryland, USA., Hargrove-Grimes P; National Center for Advancing Translational Sciences/National Institutes of Health, Bethesda, Maryland, USA., Schaudien D; Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany., Hahn K; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kühnlenz J; Bayer SAS, CropScience, Pathology & Mechanistic Toxicology, Sophia Antipolis, France., Ashton RS; University of Wisconsin-Madison, Madison, Wisconsin, USA.; Neurosetta LLC, Madison, Wisconsin, USA., Tseng M; Genentech, South San Francisco, California, USA., Reichelt M; Genentech, South San Francisco, California, USA., Laing ST; Genentech, South San Francisco, California, USA., Kiyota T; Genentech, South San Francisco, California, USA., Chamanza R; Johnson & Johnson Innovative Medicine, High Wycombe, UK., Sura R; Gilead Sciences Inc., Foster City, California, USA., Tomlinson L; Pfizer Inc., Drug Safety Research and Development, Cambridge, Massachusetts, USA.

Publikováno v: Toxicologic pathology [Toxicol Pathol] 2024 Feb; Vol. 52 (2-3), pp. 123-137. Date of Electronic Publication: 2024 Jun 18.